Extract from the Register of European Patents

EP About this file: EP2736501

EP2736501 - INTRATHECAL OR EPIDURAL ADMINISTRATION OF 3-[(1S,2S)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL]PHENOL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.10.2018
Database last updated on 28.03.2026
FormerThe patent has been granted
Status updated on  17.11.2017
FormerGrant of patent is intended
Status updated on  20.07.2017
FormerExamination is in progress
Status updated on  30.05.2017
FormerGrant of patent is intended
Status updated on  24.01.2017
FormerExamination is in progress
Status updated on  08.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Grünenthal GmbH
Zieglerstrasse 6
52078 Aachen / DE
[2017/51]
Former [2014/23]For all designated states
Grünenthal GmbH
Zieglerstrasse 6
52078 Aachen / DE
Inventor(s)01 / BLOMS-FUNKE, Petra
Gerhart-Hauptmann Strasse 36
52146 Würselen / DE
02 / SAUNDERS, Derek John
Försterstrasse 19
52072 Aachen / DE
03 / LANG, Eric
64 Ashford Drive
Plainsboro, NJ 08536 / US
 [2014/23]
Representative(s)Brosch, Oliver, et al
Kutzenberger Wolff & Partner
Waidmarkt 11
50676 Köln / DE
[N/P]
Former [2014/23]Brosch, Oliver, et al
Kutzenberger Wolff & Partner
Theodor-Heuss-Ring 23
50668 Köln / DE
Application number, filing date12747973.127.07.2012
[2017/51]
WO2012EP03186
Priority number, dateUS201161513163P29.07.2011         Original published format: US 201161513163 P
[2014/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013017233
Date:07.02.2013
Language:EN
[2013/06]
Type: A1 Application with search report 
No.:EP2736501
Date:04.06.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 07.02.2013 takes the place of the publication of the European patent application.
[2014/23]
Type: B1 Patent specification 
No.:EP2736501
Date:20.12.2017
Language:EN
[2017/51]
Search report(s)International search report - published on:EP07.02.2013
ClassificationIPC:A61K31/137, A61K45/06, A61P25/04, A61K9/00
[2014/23]
CPC:
A61K9/0085 (EP,US); A61K31/137 (EP,US); A61K45/06 (EP,US);
A61P25/00 (EP); A61P25/04 (EP); A61K31/135 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/23]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:INTRATHEKALE ODER EPIDURALE VERABREICHUNG VON 3-[(1S,2S)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL]PHENOL[2017/08]
English:INTRATHECAL OR EPIDURAL ADMINISTRATION OF 3-[(1S,2S)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL]PHENOL[2014/23]
French:ADMINISTRATION INTRATHÉCALE OU ÉPIDURALE DE 3-[(1S,2S)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL]PHENOL[2017/08]
Former [2014/23]INTRATHEKALE ODER EPIDURALE VERABREICHUNG VON 3-[(1S,2S-)3-(DIMETHYLAMINO-)1-ETHYL-2-METHYLPROPYL-]PHENOL
Former [2014/23]ADMINISTRATION INTRATHÉCALE OU ÉPIDURALE DE 3-[(1S,2S)-3-(DIMÉTHYLAMINO)-1-ÉTHYL-2-MÉTHYL-PROPYL]-PHÉNOL
Entry into regional phase28.02.2014National basic fee paid 
28.02.2014Designation fee(s) paid 
28.02.2014Examination fee paid 
Examination procedure28.02.2014Examination requested  [2014/23]
22.09.2014Amendment by applicant (claims and/or description)
27.01.2016Despatch of a communication from the examining division (Time limit: M06)
05.08.2016Reply to a communication from the examining division
08.09.2016Despatch of a communication from the examining division (Time limit: M02)
08.11.2016Reply to a communication from the examining division
25.01.2017Communication of intention to grant the patent
19.05.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
21.07.2017Communication of intention to grant the patent
10.11.2017Fee for grant paid
10.11.2017Fee for publishing/printing paid
10.11.2017Receipt of the translation of the claim(s)
Divisional application(s)EP17196884.5  / EP3300726
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.01.2016
Opposition(s)21.09.2018No opposition filed within time limit [2018/48]
Fees paidRenewal fee
14.07.2014Renewal fee patent year 03
10.07.2015Renewal fee patent year 04
11.07.2016Renewal fee patent year 05
12.07.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL20.12.2017
MK20.12.2017
SM20.12.2017
[2020/34]
Former [2020/31]MK20.12.2017
SM20.12.2017
Former [2018/40]SM20.12.2017
Cited inInternational search[Y]   TZSCHENTKE T M ET AL: "Tapentadol hydrochloride: Analgesic mu-opioid receptor agonist noradrenaline reuptake inhibitor", DRUGS OF THE FUTURE 2006 ES LNKD- DOI:10.1358/DOF.2006.031.12.1047744, vol. 31, no. 12, 2006, pages 1053 - 1061, XP002438122, ISSN: 0377-8282

DOI:   http://dx.doi.org/10.1358/dof.2006.031.12.1047744
by applicant  DAVIS ET AL., RESPIRATORY CARE JOUMAL, vol. 44, no. 1, 1999
   PURCELL-JONES ET AL.: "The use of opioids in neonates. A retrospective study of 933 cases", ANAESTHESIA, vol. 42, no. 12, 1987, pages 1316 - 20
   COLLINS ET AL.: "Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus", ANESTH ANALG, vol. 64, no. 11, 1985, pages 1078 - 80
   LYNN ET AL.: "Morphine pharmacokinetics in early infancy", ANESTHESIOLOGY, vol. 66, no. 2, 1987, pages 136 - 9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.